echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Diabetologia: Long-term use of metformin in patients with type 2 diabetes is associated with the risk of pneumonia and related deaths

    Diabetologia: Long-term use of metformin in patients with type 2 diabetes is associated with the risk of pneumonia and related deaths

    • Last Update: 2021-09-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Purpose: The long-term effect of metformin on the increased risk of severe respiratory infections in patients with type 2 diabetes remains unclear


    Methods: Researchers conducted a retrospective analysis of 22,638 patients with type 2 diabetes registered in the Hong Kong Diabetes Registry from 2001 to 2018 and followed up until December 31, 2019


    - 1 - 2

    Results: The overlap-weighted analysis showed that compared with those using other GLDs, the risk of first hospitalization for pneumonia in metformin patients was 0.


    There is also a negative correlation between the exposure time of metformin ( the proportion of the duration of metformin prescription used in the total follow-up time ) and the pneumonia event.


    The graph shows the relationship between hospitalizations for pneumonia during metformin observation (a) and related pneumonia deaths (b), as well as the relationship between the average daily dose of metformin in the overlapping weighted cohort and the risk of first pneumonia hospitalization (c)


    The graph shows the relationship between hospitalizations for pneumonia during metformin observation (a) and related pneumonia deaths (b), as well as the relationship between the average daily dose of metformin in the overlapping weighted cohort and the risk of first pneumonia hospitalization (c)


    Pneumonia-related death was defined as death from any cause ≤ 30 days after the first pneumonia hospitalization


    Long-term use of metformin is associated with reduced risk of pneumonia and pneumonia-related deaths

    Original source

    Aimin Yang,Mai Shi,Hongjiang,et al, WuLong-term metformin use and risk of pneumonia and related death in type 2 diabetes: a registry-based cohort study.


    WuLong-term metformin use and risk of pneumonia and related death in type 2 diabetes: a registry-based cohort study.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.